Raphaël Rousseau
Corporate Officer/Principal presso DAY ONE BIOPHARMACEUTICALS, INC.
Profilo
Raphaël Rousseau is a Strategic Advisor at Day One Biopharmaceuticals, Inc. He previously worked as a Senior Group Medical Director at Genentech, Inc. from 2012 to 2017 and as a Senior Medical Director at Roche Corp.
from 2010 to 2012.
He also served as the Chief Medical Officer & Executive Vice President at Gritstone bio, Inc. from 2017 to 2021.
Prior to his industry experience, he worked as a Professor at Université Claude Bernard Lyon 1.
Dr. Rousseau holds doctorate degrees from Université Paris Diderot-Paris 7 and Université de Paris 5 René Descartes.
Posizioni attive di Raphaël Rousseau
Società | Posizione | Inizio |
---|---|---|
DAY ONE BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2024 |
Precedenti posizioni note di Raphaël Rousseau
Società | Posizione | Fine |
---|---|---|
GRITSTONE BIO, INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 01/03/2017 |
Roche Corp. | Chief Tech/Sci/R&D Officer | 01/06/2012 |
Université Claude Bernard Lyon 1 | Corporate Officer/Principal | - |
Formazione di Raphaël Rousseau
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
GRITSTONE BIO, INC. | Health Technology |
DAY ONE BIOPHARMACEUTICALS, INC. | Health Technology |
Aziende private | 4 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Université Paris Diderot-Paris 7 | Consumer Services |
Roche Corp. | |
Université de Paris 5 René Descartes | Consumer Services |
- Borsa valori
- Insiders
- Raphaël Rousseau